GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Future 3-5Y EPS without NRI Growth Rate

SillaJen (XKRX:215600) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 28, 2025)


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, SillaJen's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of SillaJen's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, SillaJen's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SillaJen's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SillaJen's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where SillaJen's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

SillaJen  (XKRX:215600) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

SillaJen Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of SillaJen's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

SillaJen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XKRX:115180 XKRX:372320 XKRX:064550 XKRX:475960 XKRX:397030 XKRX:389650 XKRX:048410 XKRX:228760 XKRX:053030 XKRX:334970 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
Website
http://www.sillajen.com
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.

SillaJen Headlines

No Headlines